Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06505447 · ClinicalTrials.gov registry record · NA

PICU-related Sleep and Circadian Dysregulation Pilot Study

A NA study of Critical Illness and Sleep Disturbance, sponsored by State University of New York at Buffalo.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06505447 is a NA study of Critical Illness and Sleep Disturbance that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 30 participants, below the 3,138-participant average among 91 other Critical Illness trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06505447, a NA study of Critical Illness and Sleep Disturbance, is actively recruiting participants, sponsored by State University of New York at Buffalo.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

A single center pilot trial investigating the feasibility of using actigraphy and salivary melatonin levels to measure the sleep and circadian rhythm of critically ill children aged 3 to 6 years old. This study will also measure the feasibility of providing daytime light exposure as well as restricting all provided nutrition to during daytime hours.

Interventions

  • OTHER Daytime light exposure
  • OTHER Daytime restricted feeding

Study Locations (1)

New York

  • John R. Oishei Children's Hospital - Buffalo

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-12-06
Est. Completion 2027-01-01
Phase NA

What the Registry Record Tells You About NCT06505447

The ClinicalTrials.gov registry entry for NCT06505447 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,138-participant average among 91 other Critical Illness trials with a reported enrollment target (99% lower). The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Critical Illness appearing as the primary indexed condition, and to 2 interventions - of which Daytime light exposure is the first listed.

NCT06505447 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06505447 about?

NCT06505447 is a clinical study titled "PICU-related Sleep and Circadian Dysregulation Pilot Study". A single center pilot trial investigating the feasibility of using actigraphy and salivary melatonin levels to measure the sleep and circadian rhythm of critically ill children aged 3 to 6 years old. This study will also measure the feasibility of providing daytime light exposure as well as restrict...

What is the current status of trial NCT06505447?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-12-06. Estimated completion is 2027-01-01.

What conditions does trial NCT06505447 study?

This clinical trial studies the following conditions: Critical Illness, Sleep Disturbance, Children, Only, Circadian Dysrhythmia.

What interventions are being tested in trial NCT06505447?

The interventions under investigation include: Daytime light exposure (OTHER), Daytime restricted feeding (OTHER).

Who is sponsoring clinical trial NCT06505447?

This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06505447 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Critical Illness

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.